TrialClinical pharmacokinetics2026

Pharmacokinetic Comparability Assessment of Tixagevimab and Cilgavimab Developed for COVID-19 Prevention and Treatment Using Standard Exposure Metrics and Partial Area Under the Curve.

Huixia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.